The need for improved diagnosis of heparin-induced thrombocytopenia.
作者信息
Christie D J
出版信息
J Lab Clin Med. 1997 Sep;130(3):242-4. doi: 10.1016/s0022-2143(97)90017-2.
PMID:9341982
Abstract
摘要
相似文献
1
The need for improved diagnosis of heparin-induced thrombocytopenia.
J Lab Clin Med. 1997 Sep;130(3):242-4. doi: 10.1016/s0022-2143(97)90017-2.
2
Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
J Lab Clin Med. 1997 Sep;130(3):278-84. doi: 10.1016/s0022-2143(97)90022-6.
3
Heparin-induced thrombocytopenia.
Methods Mol Biol. 2013;992:301-18. doi: 10.1007/978-1-62703-339-8_23.
4
Heparin-induced thrombocytopenia: a ten-year retrospective.
Annu Rev Med. 1999;50:129-47. doi: 10.1146/annurev.med.50.1.129.
5
New approaches to the diagnosis of heparin-induced thrombocytopenia.
Chest. 2005 Feb;127(2 Suppl):35S-45S. doi: 10.1378/chest.127.2_suppl.35S.
6
Heparin-induced thrombocytopenia: diagnosis and management.
Circulation. 2004 Nov 2;110(18):e454-8. doi: 10.1161/01.CIR.0000147537.72829.1B.
7
Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
Am J Kidney Dis. 2009 Aug;54(2):361-74. doi: 10.1053/j.ajkd.2009.03.012. Epub 2009 May 29.
8
Serotonin release assay (SRA)-negative HIT, a newly recognized entity: Implications for diagnosis and management.
Thromb Res. 2018 Dec;172:169-171. doi: 10.1016/j.thromres.2018.10.022. Epub 2018 Oct 27.
9
Improving the laboratory diagnosis of heparin-induced thrombocytopenia.
Am J Med. 2003 May;114(7):609-10. doi: 10.1016/s0002-9343(03)00138-4.
10
Heparin-induced thrombocytopenia in the ICU: an overview.
Crit Care. 2011;15(2):211. doi: 10.1186/cc9993. Epub 2011 Mar 22.
Zotero 插件